ArticleCancers2024

The Association of Immune-Related Adverse Events with the Efficacy of Atezolizumab in Previously Treated Advanced Non-Small-Cell Lung Cancer Patients: A Single-Center Experience.

Filip Marković et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.